Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan with or without Simvastatin in Relapsed ES-SCLC
NCT04985201Phase 2Unknown
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Nov 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simvastatin in small cell lung cancer (SCLC), sponsored by Shanghai Pulmonary Hospital. Status: unknown.
02
Drugs
simvastatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT04985201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04985201.